When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TAK - Ovid's soticlestat shows encouraging action in rare epileptic disorders
Takeda Pharmaceutical Company Limited American Depositary Shares
Ovid Therapeutics (OVID-9.7%) announces preliminary data from an ongoing open-label Phase 2 clinical trial, ARCADE, evaluating soticlestat in patients with CDKL5 deficiency disorder (CDD) and Dup15q syndrome (Dup15q), two rare developmental and epileptic encephalopathies that are highly resistant to treatment.
More news on: Ovid Therapeutics Inc., Takeda Pharmaceutical Company Limited, Healthcare stocks news, Stocks on the move,